Home Tags Esketamine
Dispensed: Change at the FDA, insurance startup financials for 2018, and the first new depression drug in 35 years
Welcome to Dispensed, Business Insider's weekly newsletter giving you a dose of pharma, biotech, and healthcare news.
Regulators just approved the first new depression drug since the 1980s, and some see blockbuster potential
A drug inspired by ketamine just became the first new type of depression drug in 35 years. The FDA approved the nasal spray made by Johnson & Johnson.
A depression drug that’s been called ‘the most important discovery in half a century’ just got a big step closer to FDA approval
Esketamine, a first-of-its-kind depression drug made by Johnson & Johnson, got a big nod on Tuesday from a group of experts convened by regulators.